Synthaverse SA GPW:SVE:
REPORTED ON TUESDAY H1 NET LOSS AT 5.3 MILLION ZLOTYS
H1 REVENUE AT 19.7 MILLION ZLOTYS
H1 OPERATING LOSS AT 4.6 MILLION ZLOTYS
Source text for Workspace:
Further company coverage:
Synthaverse H1 Net Loss At 5.3 Mln Zlotys
SYNTHAVERSE Spolka Akcyjna on 6ix
Earlier from SYNTHAVERSE Spolka Akcyjna
Later from SYNTHAVERSE Spolka Akcyjna
- Synthaverse Receives Marketing Authorization For Onko BCG Drug In The Netherlands
- Synthaverse Q3 Net Loss 7.7 Million Zlotys
- Synthaverse Appoints Artur Chodkowski As CEO
- Synthaverse Gets Marketing Authorization For Onko BCG In Serbia
- Synthaverse Receives Marketing Authorization For Onko BCG Medicinal Product In Ecuador
Follow SYNTHAVERSE Spolka Akcyjna into a list and get an email when it puts out news.
Follow SYNTHAVERSE Spolka Akcyjna